Science

LONDON, Oct 17 (Reuters) – A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients. The decision, described by the scientists involved as “disproportionate and poorly justified”, is being seen as a victory for activists
0 Comments
BAIKONUR COSMODROME, Kazakhstan (Reuters) – The two-man U.S.-Russian crew of a Soyuz spacecraft taking them to the orbiting International Space Station had to make a dramatic emergency landing in Kazakhstan on Thursday when a rocket failed in mid-air. U.S. astronaut Nick Hague and Russian cosmonaut Alexei Ovchinin landed safely without harm and rescue crews who
0 Comments
TEL AVIV (Reuters) – Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors. The trials will evaluate the safety and tolerability of Compugen’s COM701, an investigational antibody, in combination with Bristol-Myers Squibb’s immune checkpoint inhibitor Opdivo. In conjunction with the collaboration, Bristol-Myers Squibb
0 Comments